Grants to Advance Research and Patient Support
Kyowa Kirin funds independent research, education, and advocacy initiatives focused on rare hematologic cancers and bone/mineral diseases, especially CTCL, prioritizing innovation and community impact.
Funder: Kyowa Kirin
Due Dates: July 31, 2026 (CTCL CME RFP) | December 10, 2020 (Patient education grants to address CTCL disparities)
Funding Amounts: $5,000–$100,000 per project (CTCL CME RFP); up to $35,000 for patient education grants; total funds available may vary by round
Summary: Supports independent research, education, and patient-focused programs addressing rare hematologic cancers and bone/mineral diseases, with emphasis on CTCL, innovation, and community impact.
Key Information: Proposals must be submitted at least 90 days before program start; grant requests should align with Kyowa Kirin's priority areas.
Description
Kyowa Kirin offers grants to advance independent research, medical education, and patient advocacy initiatives that improve outcomes for patients, families, and healthcare professionals. The funding focuses on rare conditions in hematologic cancers and diseases—particularly cutaneous T-cell lymphoma (CTCL), mycosis fungoides, and Sézary syndrome—as well as bone and mineral diseases. Priority is given to projects involving advanced therapeutic antibodies, hematopoietic stem cell gene therapies, and initiatives that address healthcare disparities or improve patient education and access. Grants are provided through an arms-length process, ensuring independence in project design and execution.
Grant categories include:
- Educational Grants: Support for independent medical education, CME programs, or fellowships.
- Research Grants: Funding for data collection, disease registries, investigator-sponsored research, and publication of research.
- Community and Advocacy Grants: Patient education resources, access to care, outreach, and addressing social determinants of health.
